Introduction
Gene One is a revolutionary Biotech company that has been forced to expand a rapid rate to meet its overall goals of becoming a leader in the biotech industry and to be on the cutting edge of technology with its new innovations. The rapid growth rate took the company from a small $2 million start-up company to more than a $400 million giant in annual sales.
The leadership team at Gene One has been the driving force for its success. Now it must take the next step and transform itself into an accredited publicly traded company, and it must prove to the industry and investors that it can. Some of the main issues and concepts brought about by the scenarios are Corporate Social Responsibility (CSR), employee retention, and changes in leadership.
The following paper addresses Gene One's current situation as well as discusses the opportunities that have developed because of the above issues. The paper will also address some of the goals that Gen One can focus on in order to improve and manage its current situation of becoming a publicly traded company, and how these goals will lead to success.
At the same time, the paper discusses how Gen One will implement its plan and optimal solution for becoming a successful publicly traded company. The paper addresses concepts such as transformational leadership, conflict management, and a company's Corporate Social Responsibility.
Situation Analysis
Issue and Opportunity Identification
The company's current leadership team currently comprises of a CEO, CFO, Marketing director, Chief Technology Officer, Human Resource director, and group of board members. The company has been performing with this leadership team up until now. Unfortunately, the company nee ...